108 related articles for article (PubMed ID: 22367793)
1. Commentary on "Cervical cancer screening in England: the past, present, and future": a comparison with Canada.
Duggan MA
Cancer Cytopathol; 2012 Apr; 120(2):97-101. PubMed ID: 22367793
[TBL] [Abstract][Full Text] [Related]
2. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
Simonella L; Canfell K
Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
[TBL] [Abstract][Full Text] [Related]
3. Cervical screening in England: the past, present, and future.
Albrow R; Kitchener H; Gupta N; Desai M
Cancer Cytopathol; 2012 Apr; 120(2):87-96. PubMed ID: 22367883
[TBL] [Abstract][Full Text] [Related]
4. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening of the uterine cervix papanicolaou smears versus state-of-the-art human papillomavirus testing.
Knight B
Cancer Cytopathol; 2012 Apr; 120(2):105-7. PubMed ID: 22367779
[TBL] [Abstract][Full Text] [Related]
6. Cervical cytology screening programs: similarities and differences between the United States and United Kingdom systems.
Wilbur DC
Cancer Cytopathol; 2012 Apr; 120(2):102-4. PubMed ID: 22367853
[No Abstract] [Full Text] [Related]
7. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
8. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix.
Parboosingh EJ; Anderson G; Clarke EA; Inhaber S; Kaegi E; Mills C; Mao Y; Root L; Stuart G; Stachenko S
CMAJ; 1996 Jun; 154(12):1847-53. PubMed ID: 8653644
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
12. Effect of a mass screening program on the risk of cervical cancer.
Louhivuori K
Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637
[TBL] [Abstract][Full Text] [Related]
13. Cervical Cancer Working Group report.
Konno R; Sagae S; Yoshikawa H; Basu PS; Hanley SJ; Tan JH; Shin HR
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i44-50. PubMed ID: 20870919
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer as a public health issue--what next?
Corusić A; Skrgatić L; Mahovlić V; Mandić V; Planinić P; Karadza M
Coll Antropol; 2010 Mar; 34(1):301-7. PubMed ID: 20432764
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
17. What happens when organization of cervical cancer screening is delayed or stopped?
Lynge E; Clausen LB; Guignard R; Poll P
J Med Screen; 2006; 13(1):41-6. PubMed ID: 16569305
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia.
Obradovic M; Mrhar A; Kos M
Eur J Public Health; 2010 Aug; 20(4):415-21. PubMed ID: 20624834
[TBL] [Abstract][Full Text] [Related]
20. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
